BR7302268D0 - Processo para obtencao de um derivado de 2-alquil-3-acil- pirazolo (1,5-a) piridina - Google Patents

Processo para obtencao de um derivado de 2-alquil-3-acil- pirazolo (1,5-a) piridina

Info

Publication number
BR7302268D0
BR7302268D0 BR732268A BR226873A BR7302268D0 BR 7302268 D0 BR7302268 D0 BR 7302268D0 BR 732268 A BR732268 A BR 732268A BR 226873 A BR226873 A BR 226873A BR 7302268 D0 BR7302268 D0 BR 7302268D0
Authority
BR
Brazil
Prior art keywords
pirazole
acyl
alkyl
obtaining
pyridine derivative
Prior art date
Application number
BR732268A
Other languages
English (en)
Portuguese (pt)
Inventor
Irikura Tsutomu
Koshirae Kikoo
Kudo Yoshitaka
Hayashi Masayuki
Hetsugi Etsujo
Hatayama Junji
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of BR7302268D0 publication Critical patent/BR7302268D0/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR732268A 1972-03-30 1973-03-29 Processo para obtencao de um derivado de 2-alquil-3-acil- pirazolo (1,5-a) piridina BR7302268D0 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47032033A JPS5229318B2 (cg-RX-API-DMAC7.html) 1972-03-30 1972-03-30

Publications (1)

Publication Number Publication Date
BR7302268D0 true BR7302268D0 (pt) 1974-08-29

Family

ID=12347544

Family Applications (1)

Application Number Title Priority Date Filing Date
BR732268A BR7302268D0 (pt) 1972-03-30 1973-03-29 Processo para obtencao de um derivado de 2-alquil-3-acil- pirazolo (1,5-a) piridina

Country Status (12)

Country Link
US (1) US3850941A (cg-RX-API-DMAC7.html)
JP (1) JPS5229318B2 (cg-RX-API-DMAC7.html)
AR (1) AR197709A1 (cg-RX-API-DMAC7.html)
BE (1) BE797554A (cg-RX-API-DMAC7.html)
BR (1) BR7302268D0 (cg-RX-API-DMAC7.html)
CA (1) CA989843A (cg-RX-API-DMAC7.html)
DE (1) DE2315801C3 (cg-RX-API-DMAC7.html)
ES (1) ES413188A1 (cg-RX-API-DMAC7.html)
FR (1) FR2182914B1 (cg-RX-API-DMAC7.html)
GB (1) GB1378375A (cg-RX-API-DMAC7.html)
HU (1) HU167305B (cg-RX-API-DMAC7.html)
SE (1) SE402592B (cg-RX-API-DMAC7.html)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097483A (en) * 1974-11-01 1978-06-27 Kyorin Pharmaceutical Co., Ltd. Pyrazolo 1,5-a!pyridines
JPS5154583A (en) * 1974-11-01 1976-05-13 Kyorin Seiyaku Kk Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
US4237300A (en) * 1975-12-09 1980-12-02 Merck & Co., Inc. Certain 6-substituted-2-pyridinamines
JPS5968553A (ja) * 1982-10-13 1984-04-18 Automob Antipollut & Saf Res Center 燃料タンク内蔵式燃料ポンプ
JPS6072975U (ja) * 1983-10-26 1985-05-22 ヤンマーディーゼル株式会社 燃料ポンプのエア抜き装置
JPH0621066B2 (ja) * 1984-03-14 1994-03-23 杏林製薬株式会社 ３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤
US4925849A (en) * 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
JPH01153633A (ja) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd 経皮吸収製剤
EP0355234A1 (en) * 1988-08-25 1990-02-28 Merrell Dow Pharmaceuticals Inc. Pyrazolopyridine derivatives as antiatherosclerotic and antihypercholesterolemic agents
JPH085790B2 (ja) * 1988-11-11 1996-01-24 杏林製薬株式会社 記憶障害改善薬
JPH0256853U (cg-RX-API-DMAC7.html) * 1989-10-04 1990-04-24
JPH06166687A (ja) * 1990-07-18 1994-06-14 Senju Pharmaceut Co Ltd ピラゾロ〔１，５−ａ〕ピリジン化合物、その製造法および用途
PT1212089E (pt) 1999-08-21 2006-08-31 Altana Pharma Ag Combinacao sinergica de roflumilast e salmeterol
GEP20074134B (en) 2002-08-19 2007-06-25 Pfizer Prod Inc Combination therapy for hyperproliferative diseases
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
NZ577031A (en) 2003-05-30 2010-09-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-CO inhibitors
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
AU2004292445B2 (en) 2003-11-21 2010-02-04 Zalicus Inc. Methods and reagents for the treatment of inflammatory disorders
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
BRPI0618379A2 (pt) 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
RU2008122978A (ru) 2005-11-09 2009-12-20 Комбинаторкс, Инкорпорейтед (Us) Способы, композиции и наборы для лечения медицинских состояний
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
MX2008015616A (es) * 2006-06-06 2009-02-11 Avigen Inc Compuestos de pirazol[1,5-a]piridina sustituidos y sus métodos de uso.
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
US20080181876A1 (en) 2007-01-30 2008-07-31 Johnson Kirk W Methods for treating acute and subchronic pain
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2559319T3 (es) 2007-06-04 2016-02-11 Synergy Pharmaceuticals Inc. Agonistas de guanilato cliclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US7536799B2 (en) * 2007-06-07 2009-05-26 Keson Industries Chalk line apparatus with strategically located chalk fill opening
WO2009008748A1 (en) * 2007-07-11 2009-01-15 Auckland Uniservices Limited Pyrazolo[1,5-a]pyridines and their use in cancer therapy
WO2009023179A2 (en) * 2007-08-10 2009-02-19 Genelabs Technologies, Inc. Nitrogen containing bicyclic chemical entities for treating viral infections
CA2696041A1 (en) 2007-08-15 2009-02-19 Kyorin Pharmaceutical Co., Ltd. Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010005520A2 (en) * 2008-06-30 2010-01-14 Concert Pharmaceuticals, Inc. 2-alkyl-3-acylpyrazolo[1,5-a]pyridine derivatives
CA2732520A1 (en) * 2008-08-05 2010-02-11 Merck Sharp & Dohme Corp. Therapeutic compounds
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
BR112012011237A2 (pt) 2009-11-13 2019-09-24 Univ Tokyo agente terapêutico e profilático para diabetes
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103764672A (zh) 2011-03-01 2014-04-30 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
ES2395801B1 (es) 2011-06-23 2014-06-06 María Carmen PARDINA PALLEJÀ "pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"
CN102617579A (zh) * 2012-03-28 2012-08-01 黑龙江大学 一种异丁司特的制备方法
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN108033959A (zh) * 2018-01-29 2018-05-15 山东省药学科学院 一种异丁司特的化学合成方法
DK3911648T3 (da) 2019-01-18 2025-01-13 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluormethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-on som pcsk9-hæmmer og fremgangsmåder til anvendelse deraf
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN113387947B (zh) * 2021-07-12 2022-07-01 中国科学院成都生物研究所 调节雌激素受体合成活性的吡唑并吡啶衍生物
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Also Published As

Publication number Publication date
BE797554A (fr) 1973-07-16
DE2315801B2 (de) 1978-06-22
DE2315801A1 (de) 1973-10-11
JPS5229318B2 (cg-RX-API-DMAC7.html) 1977-08-01
FR2182914B1 (cg-RX-API-DMAC7.html) 1976-05-14
HU167305B (cg-RX-API-DMAC7.html) 1975-09-27
SE402592B (sv) 1978-07-10
US3850941A (en) 1974-11-26
AR197709A1 (es) 1974-04-30
FR2182914A1 (cg-RX-API-DMAC7.html) 1973-12-14
ES413188A1 (es) 1976-01-16
AU5376173A (en) 1974-09-26
DE2315801C3 (de) 1979-02-22
GB1378375A (en) 1974-12-27
JPS4897898A (cg-RX-API-DMAC7.html) 1973-12-13
CA989843A (en) 1976-05-25

Similar Documents

Publication Publication Date Title
BR7302268D0 (pt) Processo para obtencao de um derivado de 2-alquil-3-acil- pirazolo (1,5-a) piridina
BR7304581D0 (pt) Processo para a obtencao de compostos de piridina substituidas
BR7305741D0 (pt) Processo para obtencao de monoacelais de 1, 2-dicetonas aromaticas
BR7302665D0 (pt) Processo para obtencao de isomaltita processo para obtencao de isomaltita
BR7303990D0 (pt) Processo para obtencao de n-fosfonometil-glicina
AR221816A1 (es) Metodo para preparar nuevos derivados de bencimidazol-2-carbamato-5(6)-sustituidos
BR7306452D0 (pt) Processo para a obtencao de eteres hidroxialquilicos de sacarose
BR7303772D0 (pt) Processo para obtencao de difenil-alcanoilamino-piridinas
BE804942A (fr) Procede de preparation de cyclohexane-diones (1,3)
BR7309305D0 (pt) Processo para obtencao de alta-aminoacil-cefalosporinas
BR7302011D0 (pt) Processo para obtencao de n.fosfonometil-glicina processo para obtencao de n. fosfonometil-glicina
BR7303730D0 (pt) Processo para a preparacao de 1-(5 alcoil-1,3,4-tiadiazol 2-il-) 1,3 dialcoil-ureias
BR7307920D0 (pt) Processo para obtencao de uma modificacao beta, estavel
BR7308593D0 (pt) Processo de preparacao de disulfuretos de ditia zalila-2,
BR7302197D0 (pt) Processo para obtencao de corantes poliazoicos
BR7301418D0 (pt) Processo para obtencao de 2-aril-v-triazois
BR7302009D0 (pt) Processo para a obtencao de acido 2,5-dicloro-3-nitro-benzoico
BR7305646D0 (pt) Processo para obtencao de um carmato
BR7300437D0 (pt) Processo para obtencao de novos pigmentos monoazoicos
BR7019265D0 (pt) Processo para a obtencao de derivados de 1,4-dhidroquinolina
BR7307856D0 (pt) Processo para a obtencao de 2-hidrazino-benzo-tiazois
BR7307069D0 (pt) Processo para obtencao de tetraquis-azo-corantes
BR7305009D0 (pt) Processo para a obtencao de 1 nitro-antraquinona
BR7307284D0 (pt) Processo para a obtencao de novos acidos naftalimido-4,5- di-carboxilicos
BR7306654D0 (pt) Processo para a obtencao de novos corantes antraquinonico